Scinovex
articleTop 10% cited

Determinants of clinical outcome and survival in acromegaly

Clinical Endocrinology · 1994 · Vol. 41(1) · pp. 95–102
C RajasooryaI.M. HoldawayPhilip WrightsonD. ScottH.K. Ibbertson

Abstract

Acromegaly has a significant adverse effect on well-being and survival. The predominant determinant of outcome is the final serum GH level following treatment.

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsGrowth Hormone and Insulin-like Growth FactorsAcromegalyMedicineDiabetes mellitusInternal medicinePegvisomantDiseaseGigantismRetrospective cohort studyMultivariate analysisPediatrics

MeSH terms

AcromegalyAdultCardiovascular DiseasesFemaleHumansHypertensionHypophysectomyMaleMiddle AgedOsteoarthritisPrognosisRetrospective StudiesGrowth HormoneTreatment OutcomeAge of Onset
Citations
564
FWCI
5.60
field-weighted impact
References
25
Percentile
97%
vs. same field & year
Citations per year
References
Basic and clinical biostatistics
The Journal of Pediatrics · 1991 · 681 citations
EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION
Clinical Endocrinology · 1980 · 467 citations
Regression Models and Life-Tables
Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 38,926 citations
ACROMEGALY
Clinical Endocrinology · 1987 · 438 citations
Nonparametric Estimation from Incomplete Observations
Journal of the American Statistical Association · 1958 · 38,793 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.